{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:16:16Z","timestamp":1791047776848,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.clbc.2016.07.002","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T08:15:58Z","timestamp":1469520958000},"page":"23-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis"],"prefix":"10.1016","volume":"17","author":[{"given":"Aki","family":"Morikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Rozner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Boire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pentsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Seidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2016.07.002_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","article-title":"Leptomeningeal carcinomatosis","volume":"25","author":"Grossman","year":"1999","journal-title":"Cancer Treat Rev"},{"issue":"24","key":"10.1016\/j.clbc.2016.07.002_bib2","article-title":"Patient characteristics and outcomes for patients with HER2-overexpressing breast cancer with brain metastases undergoing radiation therapy in the pre- and post adjuvant trastuzumab era","volume":"73","author":"Morikawa","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2016.07.002_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11060-013-1092-8","article-title":"A\u00a0retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer","volume":"113","author":"Le Rhun","year":"2013","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.clbc.2016.07.002_bib4","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.ejca.2004.08.012","article-title":"The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study","volume":"40","author":"Boogerd","year":"2004","journal-title":"Eur J Cancer"},{"issue":"26","key":"10.1016\/j.clbc.2016.07.002_bib5","article-title":"Radiation therapy for breast cancer with central nervous system metastases: a contemporary experience at Memorial Sloan-Kettering Cancer Center","volume":"31","author":"Morikawa","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.07.002_bib6","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.ijrobp.2011.02.027","article-title":"Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases","volume":"82","author":"Sperduto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.07.002_bib7","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1200\/JCO.2014.58.8517","article-title":"Validation and development of a modified breast graded prognostic assessment as a tool for survival in patients with breast cancer and brain metastases","volume":"33","author":"Subbiah","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.07.002_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejca.2015.12.021","article-title":"Leptomeningeal metastasis: clinical experience of 519 cases","volume":"56","author":"Hyun","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2016.07.002_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10549-014-3054-z","article-title":"Leptomeningeal disease and breast cancer: the importance of tumor subtype","volume":"146","author":"Abouharb","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2016.07.002_bib10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11060-013-1083-9","article-title":"The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer","volume":"112","author":"Sperduto","year":"2013","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.clbc.2016.07.002_bib11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ijrobp.2014.06.063","article-title":"Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgery","volume":"90","author":"Yang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.07.002_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-013-1175-6","article-title":"Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis","volume":"114","author":"Yust-Katz","year":"2013","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.clbc.2016.07.002_bib13","first-page":"307","article-title":"Breast cancer brain metastases: new directions in systemic therapy","volume":"7","author":"Lin","year":"2013","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.clbc.2016.07.002_bib14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1200\/JCO.2007.12.3588","article-title":"Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer","volume":"26","author":"Lin","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.07.002_bib15","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1158\/1078-0432.CCR-08-1080","article-title":"Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer","volume":"15","author":"Lin","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2016.07.002_bib16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s11060-011-0629-y","article-title":"Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases","volume":"105","author":"Lin","year":"2011","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.clbc.2016.07.002_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/neuonc\/nou141","article-title":"Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study","volume":"17","author":"Morikawa","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.clbc.2016.07.002_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13550-015-0103-5","article-title":"Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer","volume":"5","author":"Saleem","year":"2015","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.clbc.2016.07.002_bib19","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/neuonc\/nou089","article-title":"Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of end points and response criteria of published randomized clinical trials","volume":"16","author":"Chamberlain","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.clbc.2016.07.002_bib20","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0b013e3181dc1a69","article-title":"Leptomeningeal metastases in the MRI era","volume":"74","author":"Clarke","year":"2010","journal-title":"Neurology"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682091630177X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682091630177X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:15:26Z","timestamp":1761513326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152682091630177X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S152682091630177X"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2016.07.002","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2016.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}